Tissue Microarray Analysis of Neuroendocrine Differentiation and Its Prognostic Significance in Breast Cancer

Human Pathology

Volumn 34, Issue 10, 2003, Pages 1001-1008

  Makretsov, Nikita ^a,c   Gilks, C Blake ^a   Coldman, Andrew J ^b   Hayes, Malcolm ^b   Huntsman, David ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c JACK BELL RESEARCH CENTRE   (Canada)

Author keywords

Breast carcinoma; Clustering analysis; Immunohistochemistry; Neuroendocrine differentiation; Tissue microarray

Indexed keywords

CHROMOGRANIN A; ESTROGEN RECEPTOR; NEURON SPECIFIC ENOLASE; PROGESTERONE RECEPTOR; SYNAPTOPHYSIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; NEUROENDOCRINE SYSTEM; PHENOTYPE; PROGNOSIS;

EID: 0142139259     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/S0046-8177(03)00411-8     Document Type: Article

References (35)

1. Azzopardi JG, Ahmed A, Millis RR: Problems in Breast Pathology, in: Bennington JL (ed): Major Problems in Pathology. WB Saunders, 1979, pp 306-308
2. Tavassoli F: A Pathology of the Breast. Elsevier, 1992, pp 331-333
3. Silva EG: Tumors of the diffuse endocrine system, histochemical and electron-optic aids, and pitfalls in diagnosis. Crit Rev Clin Lab Sci 21:19-49, 1984
4. Andreola S, Di Re E, Merson M, et al: Immunohistochemical study of ten cases of argyrophilic carcinoma (carcinoid) of the breast. Tumori 74:295-302, 1988
5. Bussolati G, Gugliotta P, Sapino A, et al: Chromogranin-reactive endocrine cells in argyrophilic carcinomas ("carcinoids") and normal tissue of the breast. Am J Pathol 120:186-192, 1985
6. Monaghan P, Roberts JD: Immunocytochemical evidence for neuroendocrine differentiation in human breast carcinomas. J Pathol 147:281-289, 1985
7. Nesland JM, Memoli VA, Holm R, et al: Breast carcinomas with neuroendocrine differentiation. Ultrastruct Pathol 8:225-240, 1985
8. Ferguson DJ, Anderson TJ: Distribution of dense core granules in normal, benign and malignant breast tissue. J Pathol 147:59-65s, 1985
9. Nesland JM, Holm R, Johannessen JV, et al: Neuron specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations. J Pathol 148:35-43, 1986
10. McCutcheon J, Walker RA: The significance of argyrophilia in human breast carcinomas. Virchows Arch A Pathol Anat Histopathol 410:369-374, 1987
11. Nesland JM, Holm R, Johannessen JV, et al: Neuroendocrine differentiation in breast lesions. Pathol Res Pract 183:214-221, 1988
12. Uccini S, Monardo F, Paradiso P, et al: Synaptophysin in human breast carcinomas. Histopathology 18:271-273s, 1991
13. Sapino A, Righi L, Cassoni P, et al: Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol 17:127-137, 2000
14. Wade PM Jr, Mills SE, Read M, et al: Small cell neuroendocrine (oat cell) carcinoma of the breast. Cancer 52:121-125 1983
15. Papotti M, Gherardi G, Eusebi V, et al: Primary oat cell (neuroendocrine) carcinoma of the breast. Report of four cases. Virchows Arch A Pathol Anat Histopathol 420:103-108s, 1992
16. Francois A, Chatikhine VA, Chevallier B, et al: Neuroendocrine primary small cell carcinoma of the breast. Report of a case and review of the literature. Am J Clin Oncol 18:133-138, 1995
17. Rasmussen BB, Rose C, Thore SM, et al: Argyrophilic cells in 202 human mucinous breast carcinomas. Relation to histopathological and clinical factors. Am J Clin Pathol 84:737-740, 1985
18. Kato N, Endo Y, Tamura G, et al: Mucinous carcinoma of the breast: A multifaceted study with special reference to histogenesis and neuroendocrine differentiation. Pathol Int 49:947-955, 1999
19. Pagani A, Papotti M, Hofler H, et al: Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot, and hybridization analyses. Am J Pathol 136:319-327s, 1990
20. Wu JT, Erickson AJ, Tsao KC, et al: Elevated serum chromogranin A is detectable in patients with carcinomas at advanced disease stages. Ann Clin Lab Sci 30:175-178, 2000
21. Sapino A, Righi L, Cassoni P, et al: Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod Pathol 14:768-776, 2001
22. Birsak CA, Janssen PJ, van Vroonhoven CC, et al: Sex steroid receptor expression in "carcinoid" tumours of the breast. Breast Cancer Res Treat 40:243-249s, 1996
23. Lilleng R, Hagmar BM, Nesland JM: C-erbB-2 protein and neuroendocrine expression in intraductal carcinomas of the breast. Mod Pathol 5:41-47, 1992
24. Nesland JM, Ottestad L, Heikilla R, et al: C-erbB-2 protein and neuroendocrine expression in breast carcinomas. Anticancer Res 11:161-167, 1991
25. Bussolati G, Papotti M, Sapino A, et al: Endocrine markers in argyrophilic carcinomas of the breast. Am J Surg Pathol 11:248-256, 1987
26. Sapino A, Papotti M, Righi L, et al: Clinical significance of neuroendocrine carcinoma of the breast. Ann Oncol 12 (suppl):S115-S117, 2001
27. Sapino A, Bussolati G: Is detection of endocrine cells in breast adenocarcinoma of diagnostic and clinical significance? Histopathology 40:211-214, 2002
28. Miremadi A, Pinder SE, Lee AH, et al: Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology 40:215-222, 2002
29. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19:403-410, 1991
30. Parker RL, Huntsman DG, Lesack DW, et al: Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol 117:723-728, 2002
31. Reiner A, Neumeister B, Spona J, et al: Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 50:7057-7061, 1990
32. Liu CL, Prapong W, Natkuman Y, et al: Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 161:1557-1564, 2002
33. Maluf HM, Koerner FC: Carcinomas of the breast with endocrine differentiation: A review. Virchows Arch 425:449-457, 1994
34. Kononen J, Bubendorf I, Kallioniemi A, et al: Tissue microarray for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847, 1998
35. Hsu FD, Nielsen TO, Alkushi A, et al: Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 15:1374-1380, 2002